Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
Clinical trial NCT01239758 · TERMINATED
Trial details
- NCT number
- NCT01239758
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.